| Quarter |
|---|
Growth YoY Revenue Growth YoY% |
OPM OPM% |
Interest Expense Interest ExpenseCr |
Depreciation DepreciationCr |
PBT PBTCr |
Growth YoY PAT Growth YoY% |
NPM NPM% |
| Quarter |
|---|
Growth YoY Revenue Growth YoY% |
OPM OPM% |
Interest Expense Interest ExpenseCr |
Depreciation DepreciationCr |
PBT PBTCr |
Growth YoY PAT Growth YoY% |
NPM NPM% |
| Financial Year | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
Revenue RevenueCr | 4 | 30 | 41 | 49 | 53 |
Growth Revenue Growth% | 746.1 | 39.8 | 19.1 | 6.6 | |
| 3 | 26 | 34 | 36 | 38 | |
| 0 | 4 | 7 | 13 | 15 | |
OPM OPM% | 6.8 | 13.7 | 16.7 | 26.8 | 28.0 |
| 0 | 0 | 0 | 0 | 0 | |
Interest Expense Interest ExpenseCr | 0 | 1 | 3 | 4 | 4 |
Depreciation DepreciationCr | 0 | 2 | 2 | 2 | 2 |
PBT PBTCr | 0 | 1 | 2 | 7 | 8 |
| 0 | 0 | 1 | 2 | 2 | |
PAT PATCr | 0 | 1 | 2 | 5 | 6 |
Growth PAT Growth% | 738.0 | 132.4 | 223.0 | 5.5 | |
NPM NPM% | 2.4 | 2.4 | 4.0 | 10.8 | 10.7 |
| 0.1 | 1.1 | 2.1 | 6.7 | 7.0 |
| Financial Year | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
Revenue RevenueCr | 4 | 30 | 41 | 49 | 53 |
Growth Revenue Growth% | 746.1 | 39.8 | 19.1 | 6.6 | |
| 3 | 26 | 34 | 36 | 38 | |
| 0 | 4 | 7 | 13 | 15 | |
OPM OPM% | 6.8 | 13.7 | 16.7 | 26.8 | 28.0 |
| 0 | 0 | 0 | 0 | 0 | |
Interest Expense Interest ExpenseCr | 0 | 1 | 3 | 4 | 4 |
Depreciation DepreciationCr | 0 | 2 | 2 | 2 | 2 |
PBT PBTCr | 0 | 1 | 2 | 7 | 8 |
| 0 | 0 | 1 | 2 | 2 | |
PAT PATCr | 0 | 1 | 2 | 5 | 6 |
Growth PAT Growth% | 738.0 | 132.4 | 223.0 | 5.5 | |
NPM NPM% | 2.4 | 2.4 | 4.0 | 10.8 | 10.7 |
| 0.1 | 1.1 | 2.1 | 6.7 | 7.0 |
| Financial Year | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
Equity Capital Equity CapitalCr | 0 | 2 | 2 | 2 | 8 |
Reserves ReservesCr | 0 | 3 | 4 | 10 | 9 |
| 12 | 14 | 19 | 21 | 14 | |
| 14 | 14 | 26 | 31 | 54 | |
| 26 | 33 | 51 | 64 | 85 | |
| 3 | 9 | 17 | 27 | 42 | |
| 24 | 24 | 34 | 37 | 44 | |
| 26 | 33 | 51 | 64 | 85 |
| Financial Year | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
Equity Capital Equity CapitalCr | 0 | 2 | 2 | 2 | 8 |
Reserves ReservesCr | 0 | 3 | 4 | 10 | 9 |
| 12 | 14 | 19 | 21 | 14 | |
| 14 | 14 | 26 | 31 | 54 | |
| 26 | 33 | 51 | 64 | 85 | |
| 3 | 9 | 17 | 27 | 42 | |
| 24 | 24 | 34 | 37 | 44 | |
| 26 | 33 | 51 | 64 | 85 |
| Financial Year | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| 3 | -2 | 1 | 4 | 2 | |
| -24 | -1 | -13 | -5 | -9 | |
| 21 | 3 | 12 | 2 | 9 | |
Net Cash Flow Net Cash FlowCr | 0 | 0 | 0 | 1 | 2 |
Free Cash Flow Free Cash FlowCr | -20 | -2 | -12 | -1 | -6 |
CFO To PAT CFO To PAT% | 3,603.4 | -217.5 | 53.6 | 66.3 | 37.4 |
CFO To EBITDA CFO To EBITDA% | 1,285.8 | -38.3 | 12.9 | 26.9 | 14.3 |
| Financial Year | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| 3 | -2 | 1 | 4 | 2 | |
| -24 | -1 | -13 | -5 | -9 | |
| 21 | 3 | 12 | 2 | 9 | |
Net Cash Flow Net Cash FlowCr | 0 | 0 | 0 | 1 | 2 |
Free Cash Flow Free Cash FlowCr | -20 | -2 | -12 | -1 | -6 |
CFO To PAT CFO To PAT% | 3,603.4 | -217.5 | 53.6 | 66.3 | 37.4 |
CFO To EBITDA CFO To EBITDA% | 1,285.8 | -38.3 | 12.9 | 26.9 | 14.3 |
| Financial Year | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | Current |
|---|---|---|---|---|---|---|
Market Cap Market CapitalizationCr | 60 | |||||
Price To Earnings Price To Earnings | 10.5 | |||||
Price To Sales Price To Sales | 1.1 | |||||
Price To Book Price To Book | 1.2 | |||||
EV To EBITDA EV To EBITDA | 6.9 | |||||
GPM GPM% | 20.8 | 37.7 | 42.2 | 73.2 | 75.2 | 75.2 |
OPM OPM% | 6.8 | 13.7 | 16.7 | 26.8 | 28.0 | 28.0 |
NPM NPM% | 2.4 | 2.4 | 4.0 | 10.8 | 10.7 | 10.7 |
ROCE ROCE% | 0.8 | 9.7 | 12.3 | 20.8 | 17.1 | 17.1 |
ROE ROE% | 46.0 | 15.2 | 26.1 | 45.7 | 32.5 | 32.5 |
ROA ROA% | 0.3 | 2.2 | 3.2 | 8.4 | 6.6 | 6.6 |
| Financial Year | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | Current |
|---|---|---|---|---|---|---|
Market Cap Market CapitalizationCr | 60 | |||||
Price To Earnings Price To Earnings | 10.5 | |||||
Price To Sales Price To Sales | 1.1 | |||||
Price To Book Price To Book | 1.2 | |||||
EV To EBITDA EV To EBITDA | 6.9 | |||||
GPM GPM% | 20.8 | 37.7 | 42.2 | 73.2 | 75.2 | 75.2 |
OPM OPM% | 6.8 | 13.7 | 16.7 | 26.8 | 28.0 | 28.0 |
NPM NPM% | 2.4 | 2.4 | 4.0 | 10.8 | 10.7 | 10.7 |
ROCE ROCE% | 0.8 | 9.7 | 12.3 | 20.8 | 17.1 | 17.1 |
ROE ROE% | 46.0 | 15.2 | 26.1 | 45.7 | 32.5 | 32.5 |
ROA ROA% | 0.3 | 2.2 | 3.2 | 8.4 | 6.6 | 6.6 |
Documents — ABH Healthcare Ltd